{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2(5)"],"submitter":["Jayaraman PS"],"pubmed_abstract":["Cholangiocarcinoma (CCA) is a disease with a very poor prognosis and limited treatment options. Although targeted therapies directed towards specific mutations found in CCA are becoming available and are showing great potential, many tumors do not carry actionable mutations and, in those that do, the emergence of drug resistance is a likely consequence of treatment. Therapeutic targeting of enzymes and other proteins that show elevated activity in CCA cells but which are not altered by mutation is a potential strategy for the treatment of target negative and drug-resistant disease. Protein kinase CK2 (CK2) is a ubiquitously expressed kinase that has increased expression and increased activity in a variety of cancer types including CCA. Several potent CK2 inhibitors are in pre-clinical deve"],"journal":["Exploration of targeted anti-tumor therapy"],"pagination":["434-447"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9400764"],"repository":["biostudies-literature"],"pubmed_title":["Targeting protein kinase CK2 in the treatment of cholangiocarcinoma."],"pmcid":["PMC9400764"],"pubmed_authors":["Jayaraman PS","Gaston K"],"additional_accession":[]},"is_claimable":false,"name":"Targeting protein kinase CK2 in the treatment of cholangiocarcinoma.","description":"Cholangiocarcinoma (CCA) is a disease with a very poor prognosis and limited treatment options. Although targeted therapies directed towards specific mutations found in CCA are becoming available and are showing great potential, many tumors do not carry actionable mutations and, in those that do, the emergence of drug resistance is a likely consequence of treatment. Therapeutic targeting of enzymes and other proteins that show elevated activity in CCA cells but which are not altered by mutation is a potential strategy for the treatment of target negative and drug-resistant disease. Protein kinase CK2 (CK2) is a ubiquitously expressed kinase that has increased expression and increased activity in a variety of cancer types including CCA. Several potent CK2 inhibitors are in pre-clinical deve","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2025-04-18T18:42:02.945Z","creation":"2025-02-19T03:29:07.883Z"},"accession":"S-EPMC9400764","cross_references":{"pubmed":["36045705"],"doi":["10.37349/etat.2021.00055"]}}